Shengda Bio-Pharm
Producer of vitamins and biological preservatives additives.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | CNY260m | Post IPO Equity | |
| Total Funding | 000k | ||
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 67 % | (9 %) | (7 %) | (1 %) | 14 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 25 % | 36 % | 21 % | 17 % | 11 % | 17 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 9 % | 23 % | 10 % | 4 % | (7 %) | 4 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 5 % | 4 % | 5 % | 5 % | 6 % | 5 % |
Source: Company filings or news article
Zhejiang Shengda Bio-Pharm Co., Ltd. (stock code: 603079) is a Chinese company focused on the research, development, production, and sale of additives for the food, feed, and pharmaceutical industries. Founded on February 8, 1999, the company is publicly traded on the Shanghai Stock Exchange. The company's legal representative and general manager is Bin Zhou.
Shengda Bio-Pharm specializes in two main product categories: vitamin products, including biotin and folic acid, and biological preservatives, such as nisin and natamycin. It is recognized as one of the earliest producers of biotin and biological preservatives in China and one of the largest suppliers of biotin globally. The company's business model involves manufacturing and selling these additives to a global client base, operating in both domestic and overseas markets. Revenue is generated through the sale of its products, which also include intermediate APIs and other functional ingredients like polylysine.
The company operates with a strong emphasis on research and development, maintaining a provincial-level technology center, a research institute, and an academician workstation. Its R&D efforts are led by professionals from national talent programs. A key subsidiary, Zhejiang Silver-Elephant Bio-engineering Co., Ltd., is a leading global producer of nisin and natamycin and was involved in drafting the national industry standards for these products in China. Shengda adheres to strict GMP management systems and has received numerous international certifications, including ISO22000, BRC, and FAMI-QS.
Keywords: food additives, feed additives, biotin, biological preservatives, nisin, folic acid, natamycin, animal nutrition, pharmaceutical ingredients, specialty chemicals